Clinical Management of Intermittent Fasting in Patients with Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Intermittent fasting is increasing in popularity as a means of losing weight and controlling chronic illness. Patients with diabetes mellitus, both types 1 and 2, comprise about 10% of the population in the United States and would likely be attracted to follow one of the many methods of intermittent fasting. Studies on the safety and benefits of intermittent fasting with diabetes are very limited though, and health recommendations unfortunately today arise primarily from weight loss gurus and animal studies. Medical guidelines on how to manage therapeutic intermittent fasting in patients with diabetes are non-existent. The evidence to build such a clinical guideline for people with a diabetes diagnosis is almost non-existent, with just one randomized trial and several case reports. This article provides an overview of the available knowledge and a review of the very limited pertinent literature on the effects of intermittent fasting among people with diabetes. It also evaluates the known safety and efficacy issues surrounding treatments for diabetes in the fasting state. Based on those limited data and a knowledge of best practices, this paper proposes expert-based guidelines on how to manage a patient with either type 1 or 2 diabetes who is interested in intermittent fasting. The safety of each relevant pharmaceutical treatment during a fasting period is considered. When done under the supervision of the patient’s healthcare provider, and with appropriate personal glucose monitoring, intermittent fasting can be safely undertaken in patients with diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2015) · Diabetes Care · doi:10.2337/dc14-2441 · Cited by 3,066 · cited 1×
“GLP-1 receptor analogues reduce hyperglycemia in a glucose-dependent manner [29] and are therefore rarely associated with hypoglycemia.”
BackgroundClinical review of antidiabetic drugs: implications for type 2 diabetes mellitus management
Chaudhury, A., Duvoor, C., Reddy Dendi, V. S., Kraleti, S., Chada, A., Ravilla, R., Marco, A., Shekhawat, N. S., Montales, M. T., Kuriakose, K., et al. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00006 · Cited by 1,500 · cited 4×
“Specific attention should be paid to three considerations: medication adjustment, frequency of glucose monitoring, and fluid intake [26].”
BackgroundInfluentialTrepanowski, J. F., Kroeger, C. M., Barnosky, A., Klempel, M. C., Bhutani, S., Hoddy, K. K., Gabel, K., Freels, S., Rigdon, J., Rood, J., et al. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.0936 · Cited by 645 · cited 2×
“Early in the study of fasting’s health effects it was hypothesized that fasting could ameliorate some of the major undesirable effects of weight loss diets [10].”
BackgroundWei, M., Brandhorst, S., Shelehchi, M., Mirzaei, H., Cheng, C. W., Budniak, J., Groshen, S., Mack, W. J., Guen, E., Di Biase, S., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aai8700 · Cited by 553 · cited 1×
“Others allow carbohydrates or macro/micro-nutrients up to a limit that will still promote ketosis and, although it is simply a low-calorie diet, due to the popularity of fasting this has been labeled a diet that mimics fasting [9].”
BackgroundHarris, L., Hamilton, S., Azevedo, L. B., Olajide, J., De Brún, C., Waller, G., Whittaker, V., Sharp, T., Lean, M., Hankey, C., et al. (2018) · JBI Database of Systematic Reviews and Implementation Reports · doi:10.11124/jbisrir-2016-003248 · Cited by 319 · cited 2×
“Some authors use it when a patient withholds caloric intake for several consecutive hours during the day (often 16 h with all energy intake during the other 8 h of the day) [5], others for a full day once or twice a week [6], and others three or four days per week [7].”
BackgroundResultCarter, S., Clifton, P. M., & Keogh, J. B. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.0756 · Cited by 299
Intermittent Fasting in Cardiovascular Disorders—An Overview
Malinowski, B., Zalewska, K., Węsierska, A., Sokołowska, M. M., Socha, M., Liczner, G., Pawlak-Osińska, K., & Wiciński, M. (2019) · Nutrients · doi:10.3390/nu11030673 · Cited by 290 · cited 2×
“For a more thorough review of human studies of the effect of intermittent fasting on changes in weight, we suggest a review paper by Malinowski and colleagues (and specifically Section 5 and Table 5 in Malinowski) [13].”
BackgroundCorley, B. T., Carroll, R. W., Hall, R. M., Weatherall, M., Parry‐Strong, A., & Krebs, J. D. (2018) · Diabetic Medicine · doi:10.1111/dme.13595 · Cited by 217 · cited 7×
“Basal Insulin (note: one study decreased basal insulin by 50% on fasting days and still had significant hypoglycemia rates [6], thus caution is required) NPH, Levemir, glargine 1%, Basaglar high Take one-third of usual dose (67% lower dose) for controlled patient; take half of usual dose (50% lower dose) for uncontrol…”
BackgroundMethodInfluential
Research works printed but not linked: 25
- Grajower, 2008, Management of diabetes mellitus on yom kippur and other Jewish fast days, Endocr. Pract., 14, 305, 10.4158/EP.ep.14.3.305 · DOI
- Grajower, 2011, 24-Hour Fasting with Diabetes: Guide to physicians advising patients on medication adjustments prior to religious observances (or outpatient surgical procedures), Diabetes Metab. Res. Rev., 27, 413, 10.1002/dmrr.1169 · DOI
- Hassanein, 2017, Diabetes and Ramadan: Practical guidelines, Diabetes Res. Clin. Pract., 126, 303, 10.1016/j.diabres.2017.03.003 · DOI · Paper page
- Bajaj, 2018, Diabetes Canada Position Statement for People with Types 1 and 2 Diabetes Who Fast During Ramadan, Can. J. Diabetes, 43, 3, 10.1016/j.jcjd.2018.04.007 · DOI
- Furmli, S., Elmasry, R., Ramos, M., and Fung, J. (2018). Therapeutic use of intermittent fasting for people with type 2 diabetes as an alternative to insulin. BMJ Case Rep. · DOI · Paper page
- Klempel, 2012, Intermittent fasting combined with calorie restriction is effective for weight loss and cardio-protection in obese women, Nutr. J., 11, 98, 10.1186/1475-2891-11-98 · DOI · Paper page
- Varady, 2011, Intermittent versus daily calorie restriction: Which diet regimen is more effective for weight loss?, Obes. Rev., 12, e593, 10.1111/j.1467-789X.2011.00873.x · DOI · Paper page
- Anton, 2017, Flipping the metabolic switch: Understanding and applying the health benefits of fasting, Obesity, 26, 254, 10.1002/oby.22065 · DOI · Paper page
- Washburn, R.L., Cox, J.E., Muhlestein, J.B., May, H.T., Carlquist, J.F., Le, V.T., Anderson, J.L., and Horne, B.D. (2019). Pilot study of novel intermittent fasting effects on metabolomics and trimethylamine N-oxide changes during 24-h water-only fasting in the FEELGOOD Trial. Nutrients, 11. · DOI · Paper page
- Paoli, A., Tinsley, G., Bianco, A., and Moro, T. (2019). The influence of meal frequency and timing on health in humans: The role of fasting. Nutrients, 11. · DOI · Paper page
- Horne, 2013, Randomized cross-over trial of short-term water-only fasting: Metabolic and cardiovascular consequences, Nutr. Metab. Cardiovasc. Dis., 23, 1050, 10.1016/j.numecd.2012.09.007 · DOI
- Barzilai, 1998, Caloric restriction reverses hepatic insulin resistance in aging rats by decreasing visceral fat, J. Clin. Investig., 101, 1353, 10.1172/JCI485 · DOI · Paper page
- Bloomgarden, 2005, Inflammation, atherosclerosis, and aspects of insulin action, Diabetes Care., 28, 2312, 10.2337/diacare.28.9.2312 · DOI
- Breen, 2011, Effects of insulin on the vasculature, Curr. Vasc. Pharmacol., 9, 321, 10.2174/157016111795495558 · doi:10.2174/157016111795495558
- Giles, 2003, The patient with diabetes mellitus and heart failure: At-risk issues, Am. J. Med., 115, 107S, 10.1016/j.amjmed.2003.09.017 · DOI
- Golbidi, 2017, Health benefits of fasting and caloric restriction, Curr. Diab. Rep., 17, 123, 10.1007/s11892-017-0951-7 · DOI · Paper page
- Horne, 2012, Relation of Routine, Periodic Fasting to Risk of Diabetes Mellitus, and Coronary Artery Disease in Patients Undergoing Coronary Angiography, Am. J. Cardiol., 109, 1558, 10.1016/j.amjcard.2012.01.379 · DOI
- Guess, N.D. (2018). Dietary interventions for the prevention of type 2 diabetes in high-risk groups: Current state of evidence and future research needs. Nutrients, 10. · DOI
- Zubrzycki, 2018, The role of low-calorie diets and intermittent fasting in the treatment of obesity and type-2 diabetes, J. Physiol. Pharmacol., 69, 663
- Yasaka, 1993, Clinical features of recurrent embolization in acute cardioembolic stroke, Stroke, 24, 1681, 10.1161/01.STR.24.11.1681 · DOI
- Nadav, 2002, Stroke in hospitalized patients: Are there special risk factors?, Cerebrovasc. Dis., 13, 127, 10.1159/000047762 · doi:10.1159/000047762
- Kalra, 2014, Alpha glucosidase inhibitors, J. Pak. Med. Assoc., 64, 474
- Schwartz, 2016, Evidence-based practice use of quick-release bromocriptine across the natural history of type 2 diabetes mellitus, Postgrad. Med., 128, 828, 10.1080/00325481.2016.1214059 · DOI
- Galderisi, 2018, Pramlintide but not liraglutide suppresses meal-stimulated glucagon responses in type 1 diabetes, J. Clin. Endocrinol. Metab., 103, 1088, 10.1210/jc.2017-02265 · DOI · Paper page
- Morales, 2014, Hypoglycemia, Am. J. Med., 127, 17, 10.1016/j.amjmed.2014.07.004 · DOI
Cited by
Clinical application of intermittent fasting for weight loss: progress and future directions
Varady, K. A., Cienfuegos, S., Ezpeleta, M., & Gabel, K. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00638-x · Cited by 357
Ibrahim, M., Davies, M. J., Ahmad, E., Annabi, F. A., Eckel, R. H., Ba-Essa, E. M., El Sayed, N. A., Hess Fischl, A., Houeiss, P., Iraqi, H., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001248 · Cited by 124
Nutrition in Patients with Type 2 Diabetes: Present Knowledge and Remaining Challenges
Petroni, M. L., Brodosi, L., Marchignoli, F., Sasdelli, A. S., Caraceni, P., Marchesini, G., & Ravaioli, F. (2021) · Nutrients · doi:10.3390/nu13082748 · Cited by 116
Napoleão, A., Fernandes, L., Miranda, C., & Marum, A. P. (2021) · Nutrients · doi:10.3390/nu13041302 · Cited by 103
Intermittent fasting for the prevention of cardiovascular disease
Allaf, M., Elghazaly, H., Mohamed, O. G., Fareen, M. F. K., Zaman, S., Salmasi, A.-M., Tsilidis, K., & Dehghan, A. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013496.pub2 · Cited by 98
Metadata
- Authors
- Grajower, M. M., & Horne, B. D.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2019-04-18
- Volume
- 11
- Issue
- 4
- Pages
- 873
- ISSN
- 2072-6643 (ISSN-L)
- OpenAlex
- W2938690204
- Cited by
- 148
- References
- 8
- FWCI
- 11.00
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.